Fourth Quarter and Full Year 2024 Outlook
The following statements are based on APEI's current expectations. These statements are forward-looking and actual results may differ materially. APEI undertakes no obligation to update publicly any forward-looking statements for any reason unless required by law. Refer to APEI's earnings conference call and presentation for further details.
Fourth Quarter 2024 Guidance | ||
(Approximate) | (% Yr/Yr Change) | |
APUS Net course registrations | 94,400 to 96,100 | 4% to 6% |
HCN Student enrollment | 3,700 | 19 % |
RU Student enrollment | 14,600 | 4 % |
- On-ground Healthcare | 6,300 | -3 % |
- Online | 8,300 | 9 % |
($ in millions except EPS) | ||
APEI Consolidated revenue | $159.0 – $164.0 | 4% to 8% |
APEI Net loss/income available to common stockholders | $9.0 – $11.0 | (20%) – (4.0%) |
APEI Adjusted EBITDA | $23.0 – $26.0 | (10%) to 2% |
APEI Diluted EPS | $0.47 – $0.56 | (26%) to (13%) |
Full Year 2024 Guidance | ||
(Approximate) | (% Yr/Yr Change) | |
($ in millions) | ||
APEI Consolidated Revenue | $620 – $625 | 3% to 4% |
APEI Net income available to common stockholders | $7-$9 | n.m. |
APEI Adjusted EBITDA | $64 – $67 | 7% to 12% |
APEI Capital Expenditure (CapEx) | $19 – $22 | 37% to 58% |